BusinessTreos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal CancerBy Nasdaq OMXApr 11, 2018, 12:15 PM UTC
BusinessTreos Bio Names Gábor Illés as Its Chief Financial OfficerBy Nasdaq OMXApr 3, 2018, 12:15 PM UTC
BusinessInnovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences CompanyBy Nasdaq OMXMar 19, 2018, 12:01 PM UTC
BusinessTreos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal CancerBy Nasdaq OMXJan 24, 2018, 1:15 PM UTC
BusinessGlobal Cancer Immunotherapy Market & Clinical Trials Outlook 2022: Download Report, Market Opportunity at USD 100 Billion, Clinical Trial Insight by Drug ClassBy Nasdaq OMXJun 26, 2017, 8:13 AM UTC
